These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33915303)

  • 61. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Integrated proteomic and phosphoproteomic analysis for characterization of colorectal cancer.
    Zhu H; Li Y; Guo J; Feng S; Ge H; Gu C; Wang M; Nie R; Li N; Wang Y; Wang H; Zhong J; Qian X; He G
    J Proteomics; 2023 Mar; 274():104808. PubMed ID: 36596410
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development.
    Kopylov AT; Stepanov AA; Malsagova KA; Soni D; Kushlinsky NE; Enikeev DV; Potoldykova NV; Lisitsa AV; Kaysheva AL
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32023884
    [No Abstract]   [Full Text] [Related]  

  • 64. IGFBP-3/transferrin/transferrin receptor 1 complexes as principal mediators of IGFBP-3 delivery to colon cells in non-cancer and cancer tissues.
    Miljuš G; Malenković V; Đukanović B; Kolundžić N; Nedić O
    Exp Mol Pathol; 2015 Jun; 98(3):431-8. PubMed ID: 25839091
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An update on microRNAs as colorectal cancer biomarkers: where are we and what's next?
    Okugawa Y; Toiyama Y; Goel A
    Expert Rev Mol Diagn; 2014 Nov; 14(8):999-1021. PubMed ID: 25163355
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Macrophage mannose receptor 1 and S100A9 were identified as serum diagnostic biomarkers for colorectal cancer through a label-free quantitative proteomic analysis.
    Fan NJ; Chen HM; Song W; Zhang ZY; Zhang MD; Feng LY; Gao CF
    Cancer Biomark; 2016; 16(2):235-43. PubMed ID: 26682511
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry.
    Sethi MK; Hancock WS; Fanayan S
    Acc Chem Res; 2016 Oct; 49(10):2099-2106. PubMed ID: 27653471
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection.
    Slaby O
    Adv Exp Med Biol; 2016; 937():153-70. PubMed ID: 27573899
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
    Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
    J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
    [TBL] [Abstract][Full Text] [Related]  

  • 70. STUDY OF LIPID BIOMARKERS OF PATIENTS WITH POLYPS AND COLORECTAL CÂNCER.
    Serafim PVP; Figueiredo AG; Felipe AV; Turco EGL; Silva IDCGD; Forones NM
    Arq Gastroenterol; 2019; 56(4):399-404. PubMed ID: 31800736
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of urinary biomarkers of colorectal cancer: Towards the development of a colorectal screening test in limited resource settings.
    Zhang L; Zheng J; Ismond KP; MacKay S; LeVatte M; Constable J; Isaac Alatise O; Peter Kingham T; Wishart DS
    Cancer Biomark; 2023; 36(1):17-30. PubMed ID: 35871322
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of actin beta-like 2 (ACTBL2) as novel, upregulated protein in colorectal cancer.
    Ghazanfar S; Fatima I; Aslam M; Musharraf SG; Sherman NE; Moskaluk C; Fox JW; Akhtar MW; Sadaf S
    J Proteomics; 2017 Jan; 152():33-40. PubMed ID: 27989943
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of Fecal M2PK as a Diagnostic Marker in Colorectal Cancer.
    Dabbous HK; Mohamed YAE; El-Folly RF; El-Talkawy MD; Seddik HE; Johar D; Sarhan MA
    J Gastrointest Cancer; 2019 Sep; 50(3):442-450. PubMed ID: 29626277
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
    de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
    J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Noninvasive Detection of Colorectal Carcinomas Using Serum Protein Biomarkers.
    Ivancic MM; Megna BW; Sverchkov Y; Craven M; Reichelderfer M; Pickhardt PJ; Sussman MR; Kennedy GD
    J Surg Res; 2020 Feb; 246():160-169. PubMed ID: 31586890
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach.
    Yu J; Zhai X; Li X; Zhong C; Guo C; Yang F; Yuan Y; Zheng S
    Sci Rep; 2017 Oct; 7(1):14265. PubMed ID: 29079854
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Proteomics of differential extraction fractions enriched for chromatin-binding proteins from colon adenoma and carcinoma tissues.
    Knol JC; de Wit M; Albrethsen J; Piersma SR; Pham TV; Mongera S; Carvalho B; Fijneman RJ; Meijer GA; Jiménez CR
    Biochim Biophys Acta; 2014 May; 1844(5):1034-43. PubMed ID: 24361553
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers.
    Ludvigsen M; Thorlacius-Ussing L; Vorum H; Stender MT; Thorlacius-Ussing O; Honoré B
    Curr Issues Mol Biol; 2021 Sep; 43(2):1043-1056. PubMed ID: 34563043
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
    Fijneman RJ; de Wit M; Pourghiasian M; Piersma SR; Pham TV; Warmoes MO; Lavaei M; Piso C; Smit F; Delis-van Diemen PM; van Turenhout ST; Terhaar sive Droste JS; Mulder CJ; Blankenstein MA; Robanus-Maandag EC; Smits R; Fodde R; van Hinsbergh VW; Meijer GA; Jimenez CR
    Clin Cancer Res; 2012 May; 18(9):2613-24. PubMed ID: 22351690
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening.
    Zhao G; Li H; Yang Z; Wang Z; Xu M; Xiong S; Li S; Wu X; Liu X; Wang Z; Zhu Y; Ma Y; Fei S; Zheng M
    Cancer Med; 2019 Sep; 8(12):5619-5628. PubMed ID: 31407497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.